Optimizing Polymyxin Combinations Against Resistant Gram-Negative Bacteria

Polymyxin combination therapy is increasingly used clinically. However, systematic investigations of such combinations are a relatively recent phenomenon. The emerging pharmacodynamic (PD) and pharmacokinetic (PK) data on CMS/colistin and polymyxin B suggest that caution is required with monotherapy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Infect Dis Ther
Autori principali: Bergen, Phillip J., Bulman, Zackery P., Landersdorfer, Cornelia B., Smith, Nicholas, Lenhard, Justin R., Bulitta, Jürgen B., Nation, Roger L., Li, Jian, Tsuji, Brian T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer Healthcare 2015
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4675771/
https://ncbi.nlm.nih.gov/pubmed/26645096
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-015-0093-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi